| Field | Specification |
|---|---|
| Target | |
| Alternative names | B-cell receptor CD22;B-lymphocyte cell adhesion molecule;BL-CAM;Sialic acid-binding Ig-like lectin 2;Siglec-2;T-cell surface antigen Leu-14;CD22;CD22;SIGLEC2; |
| UniProt # | |
| Host | |
| Clonality | |
| Isotype | |
| Reactivity | |
| Applications | |
| Immunogen | A synthetic peptide corresponding to a sequence at the C-terminus of human CD22, different from the related mouse sequence by ten amino acids. |
| Molecular weight | |
| Purification | |
| Reconstitution | |
| Cellular localization | |
| Concentration | |
| Form | Lyophilized |
| Storage | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
This rabbit polyclonal antibody recognizes B-cell receptor CD22 in human, mouse and rat samples and is validated for flow cytometry, IHC and Western blot. The predicted molecular weight is 95.3 kDa, and the supplier reports an observed band at about 140 kDa.
CD22 is a Siglec (sialic acid-binding immunoglobulin-like lectin) expressed on B cells that binds α2,6-linked sialic acid. Through ITIM motifs in its cytoplasmic tail it dampens B-cell receptor signaling, and it serves as a B-cell marker and a target in B-cell lymphoma and leukemia research.
| Target | B-cell receptor CD22 (gene CD22; UniProt P20273, human) |
|---|---|
| Host / Clonality / Isotype | Rabbit / Polyclonal / Rabbit IgG |
| Reactivity | Human, Mouse, Rat |
| Form | Lyophilized |
| Formulation | Per vial: 0.9 mg NaCl; 0.2 mg Na2HPO4; 0.05 mg NaN3; plus stabilizers |
| Calculated MW | 95.3 kDa |
| Observed MW | 140 kDa |
| Storage | As supplied: −20 °C for up to 12 months from receipt. After reconstitution: 4 °C for up to 1 month, or aliquot and keep at −20 °C for up to 6 months. Avoid repeated freeze–thaw cycles. |
Validated Applications
| IHC (paraffin sections) | 0.5–1 µg/mL (Human) |
|---|---|
| Western blot | 0.1–0.5 µg/mL (Human, Mouse, Rat) |
| Flow cytometry | 1–3 µg/1×106cells (Human) |
Samples with a confirmed band (WB): human Daudi cells, human Raji cells, human Ramos cells.
Recommended loading (WB): 20–40 µg of total protein per lane.
Conditions in the example images (WB): 5–20% gradient SDS-PAGE under reducing conditions, 30 µg lysate per lane, transfer to nitrocellulose membrane, blocking in 5% non-fat milk, primary antibody at 0.5 µg/mL overnight at 4 °C, HRP-conjugated secondary antibody at 1:5000, ECL detection.
Samples with confirmed staining (IHC): human tonsil tissue.
Recommended antigen retrieval: heat-mediated, in TE buffer (pH 9.0); citrate buffer (pH 6.0) can be used instead.
Conditions in the example images (IHC): heat-mediated antigen retrieval in EDTA buffer (pH 8.0).
Samples with a confirmed signal (flow cytometry): Raji cells.
Immunogen
Synthetic peptide from the C-terminal region of human CD22. It differs from the mouse sequence at ten residues.
Reactivity Notes
The supplier lists reactivity with human, mouse and rat. UniProt places B-cell receptor CD22 in the cell membrane. Tissue expression noted by UniProt (human): B-lymphocytes. The samples tested by the supplier (listed above) are a practical starting point for positive controls.
Safety
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
Zhao Yaqi et al. (2024) Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL. Blood. 10.1182/blood.2024023930
Huang Jinyu et al. (2013) S100+ cells: A new neuro-immune cross-talkers in lymph organs. Scientific Reports. 10.1038/srep01114
